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Of 362 fecal samples collected from children with acute 
gastroenteritis in Sri Lanka during 2005–2006, 30 (8.3%) 
were positive for human parechovirus (HPeV) by reverse 
transcription–PCR. A novel HPeV, designated as HPeV10, 
was identiﬁ  ed in 2 samples by sequence analysis of the viral 
protein 1 gene of the detected HPeVs. 
P
arechoviruses are small, nonenveloped, positive-sense, 
single-stranded RNA viruses belonging to the large 
family of Picornaviridae, a highly diverse family of impor-
tant pathogens of humans and animals. The genus Parecho-
virus is composed of 2 species: Ljungan virus, isolated 
from bank voles (1), and human parechovirus (HPeV), a 
frequent human pathogen. The HPeV genome is ≈7.3 kb 
long and contains a large open reading frame coding for 
a single polyprotein. The polyprotein is cleaved posttrans-
lationally into 3 structural proteins (viral protein [VP] 0, 
VP3, and VP1) and 7 nonstructural proteins (2A–2C and 
3A–3D) (2,3).
Previous ﬁ  ndings have shown the genetic variability 
of HPeVs, and the number of newly identiﬁ  ed HPeV gen-
otypes has been on the increase (4–6). To date there have 
been 9 published HPeV types assigned as types 1–8 and 14 
(www.picornaviridae.com/parechovirus/hpev/hpev.htm).
We identiﬁ  ed a novel HPeV designated as HPeV10 that 
was detected in the stool samples of children in Sri Lanka 
who had acute gastroenteritis.
The Study
We used reverse transcription–PCR to screen 362 
fecal samples collected from child inpatients with acute 
gastroenteritis at a hospital in Kandy, Sri Lanka, dur-
ing September 2005 through August 2006  for HPeV. 
Informed consent was obtained from the mothers of all 
enrolled patients. The study was approved by the Univer-
sity of Peradeniya’s Committee on Research and Ethical 
Review. Reverse transcription was performed by using 
random primer, and PCR was conducted by using primers 
ev22(+) and ev22(–) to amplify a 270-bp PCR product of 
the 5′ untranslated region (7).
For genotyping, samples positive for HPeV by the 
screening PCR were subjected to a 2-step PCR to am-
plify the VP1 sequence. The ﬁ  rst PCR was done by us-
ing 2 newly developed primers, Cap-parEcho-F (5′-
TCHACWTGGATGMGRAARAC-3′) and Cap-parEcho-R 
(5′-TCYARYTCACAYTCYTCYTC-3′), which were de-
signed outside the VP1 region, whereas the nested PCR was 
performed by using the inner primer pair, VP1-parEchoF1 
and VP1-parEchoR1, described by Benschop et al. (8). 
The PCR amplicons of the VP1 gene were puriﬁ  ed and se-
quenced in both directions by using the BigDye Terminator 
Cycle Sequencing kit (Perkin Elmer-Applied Biosystems, 
Inc., Foster City, CA, USA). The inner primers for ampli-
ﬁ  cation of VP1 gene were used as sequencing primers. The 
sequence data were collected by an ABI Prism 310 Genetic 
Analyzer (Perkin Elmer-Applied Biosystems, Inc.).
Comparison analysis of the VP1 sequence was con-
ducted between the obtained HPeV strains and reference 
HPeV strains of the 9 deﬁ  ned genotypes (HPeV1-8 and 
HPeV14) available in the GenBank database. The sequence 
data and the phylogenesis were analyzed by using BioEdit 
version 7.0.5 (www.mbio.ncsu.edu/BioEdit/bioedit.html). 
A parsimony analysis was also conducted by using MEGA 
version 3.1 to determine the evolutionary relationship 
among studied sequences (9). The method was performed 
using close-neighbor interchange with a random option and 
with 500 bootstrap repetitions.
Of the 362 samples tested, 30 were positive for HPeV; 
detection rate was 8.3%. Of these, 12 isolates were selected 
for ampliﬁ  cation and sequencing of the VP1 gene. Ten of 
the 12 sequenced strains were of known and well-charac-
terized genotypes (genotype 1, 7 samples; genotype 4, 3 
samples). These strains were not further analyzed. Two 
remaining strains (LK-103 and LK-106, accession nos. 
GQ402515 and GQ402516, respectively) showed VP1 se-
quences that clustered together with none of the known 9 
HPeV genotypes (HPeV1-8, 14) in the phylogenetic anal-
ysis (Figure). Nucleotide and amino acid similarities be-
tween these 2 strains were 94.4% and 99.5%, respectively 
(data not shown).
Identical matrix analysis of VP1 nucleotide sequences 
of the 2 strains from Sri Lanka and global reference strains 
of the 9 known genotypes available in GenBank databases 
was then performed. The results showed that the 2 studied 
strains had highest mean nucleotide and amino acid simi-
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larities with HPeV3, 69.1% and 82.8%, respectively, and 
that the lowest mean nucleotide and amino acid similarities 
were found between the 2 studied strains and HPeV5, of 
54.5% and 60.9%, respectively (Table). Therefore, these 
strains were expected to be classiﬁ  ed into a new or previ-
ously unpublished HPeV (HPeV 9-13) genotype according 
to proposed criteria for assigning HPeV genotypes (10).
The VP1 sequences of the strains studied were sub-
mitted to the International Committee on Taxonomy of Vi-
ruses Picornavirus Study Group (www.picornastudygroup.
com/types/index.html) to identify their genotype. These 2 
strains were designated HPeV10 with their nucleotide and 
amino acid identities of 88.0% and 98.6% (strain LK-106) 
and 87.7% and 97.7% (strain LK-103) to the prototype 
BAN2004-10903 (M.S. Oberste et al., unpub. data).
The alignment of deduced amino acid sequences of the 
strains studied and global HPeV reference strains of HPeVs 
genotypes 1–8 and 14 showed that the arginine-glycine-as-
partic acid (RGD) motif, which is considered to be criti-
cal for HPeV1 entry (11), was neither present in the strains 
studied nor among reference strains of HPeV3, HPeV7, 
HPeV8, and HPeV14 (4–6,12). Therefore, like HPeV3, 
HPeV7, HPeV8, and HPeV14, the lack of RGD motif in 
HPeV10 may imply that HPeV10 has an RGD-independent 
entry pathway.
Conclusions
We found HPeV in stool samples collected from hospi-
talized children in Sri Lanka who had acute gastroenteritis. 
The identiﬁ  ed HPeV10 in this study was more closely ge-
netically related to HPeV3 than to the remaining published 
HPeVs. Together with the unpublished ﬁ  ndings of Oberste 
et al., this study provides basic data for future research into 
HPeV10. In addition, when taken together with other previ-
ous ﬁ  ndings, our ﬁ  ndings suggest that HPeV should be in-
cluded in the spectrum of viruses for which routine screen-
ing is conducted among children with acute gastroenteritis.
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Figure. Phylogenetic tree constructed from nucleotide sequences 
of the structural viral protein gene of the strains studied and 
reference human parechovirus (HPeV) strains with 500 bootstrap 
repetitions. Percentage bootstrap values >70% are shown at the 
branch nodes. The studied HPeV strains are in boldface; their 
nucleotide sequences have been deposited in GenBank under 
accession nos. GQ402515 and GQ402516. Scale bar indicates 
nucleotide substitutions per site.
Table. Mean percentage nucleotide similarities between HPeV genotypes* 
HPeV genotype  1 2345678 1 0 1 4
1 
2 64.1
3 58.0 59.0
4 63. 9  63.2 59.5
5 61.6 60.7 53.5 65.8
6 64.7 60.1 61.0 61.8 60.8
7 57.3 59.9 63.8 58.7 56.0 54.1
8 61.6 61.7 61.2 62.3 57.7 59.1 62.1
10 60.5 56.8 69.1 60.9 54.5 55.9 66.0 63.6
14 59.8 58.4 65.9 58.4 56.2 56.6 66.2 62.5 68.8
*HPeV, human parechovirus. Ms Pham is a physician and a PhD candidate at Tokyo Uni-
versity, Japan. Her current research interest focuses on less-ex-
plored viral pathogens of acute gastroenteritis in humans.
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